Ma, L., Bian, X., & Lin, W. (2021). Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer. J Exp Clin Cancer Res.
Chicago-tyylinen lähdeviittausMa, Liying, Xing Bian, ja Wenchu Lin. "Correction To: The Dual HDAC-PI3K Inhibitor CUDC-907 Displays Single-agent Activity and Synergizes With PARP Inhibitor Olaparib in Small Cell Lung Cancer." J Exp Clin Cancer Res 2021.
MLA-viiteMa, Liying, Xing Bian, ja Wenchu Lin. "Correction To: The Dual HDAC-PI3K Inhibitor CUDC-907 Displays Single-agent Activity and Synergizes With PARP Inhibitor Olaparib in Small Cell Lung Cancer." J Exp Clin Cancer Res 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.